Cantor Fitzgerald upgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Hold to Buy with a price target of $60.00 (from $59.00).

This article: 164 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE